Showing results (821-830 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|December 5, 2025
Saddlepoint p-values for the class of bivariate two-sample tests under generalized randomized block designAbd El-Raheem M Abd El-Raheem, Ibrahim A A Shanan, Mona HosnyJournal of Biopharmaceutical Statistics|November 13, 2025
Power priors and type I error control: constrained borrowing of external control dataSe Yoon LeeJournal of Biopharmaceutical Statistics|July 18, 2014
Clinical development and trial design of biosimilar products: a Japanese perspectiveMasayuki Nagasaki, Yuki AndoJournal of Biopharmaceutical Statistics|July 19, 2014
Covariate effect on constancy assumption in noninferiority clinical trialsSiyan Xu, Kerry Barker, Sandeep Menon, et al.Journal of Biopharmaceutical Statistics|July 18, 2014
Applications of the bayesian prior information to evaluation of equivalence of similar biological medicinal productsShih-Ting Chiu, Jen-Pei Liu, Shein-Chung ChowJournal of Biopharmaceutical Statistics|January 22, 2013
Identifying potential adverse events dose-response relationships via Bayesian indirect and mixed treatment comparison modelsHaoda Fu, Karen L Price, Mary E Nilsson, et al.Journal of Biopharmaceutical Statistics|January 22, 2013
Sample size of thorough QTc clinical trial adjusted for multiple comparisonsYi Tsong, Anna Sun, Seung-Ho KangJournal of Biopharmaceutical Statistics|January 22, 2013
Regulatory issues of propensity score methodology application to drug and device safety studiesMark S Levenson, Lilly Q YueJournal of Biopharmaceutical Statistics|January 22, 2013
Testing a noninferiority hypothesis: what to anticipate when the adverse event is rareBradley W McEvoy, Eric Y FrimpongJournal of Biopharmaceutical Statistics|January 22, 2013
A Bayesian group sequential approach to safety signal detectionWenfeng Chen, Naiqing Zhao, Guoyou Qin, et al.Pageof 216